Performance Characteristics of Plasma Amyloid β 40 and 42 Assays

BACKGROUND: Identifying biomarkers of Alzheimer disease (AD) risk will be critical to effective AD prevention. Levels of circulating amyloid β (Aβ) 40 and 42 may be candidate biomarkers. However, properties of plasma Aβ assays must be established. METHODS: Using five different protocols, blinded sam...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Okereke, Olivia I., Xia, Weiming, Irizarry, Michael C., Sun, Xiaoyan, Qiu, Wei Q., Fagan, Anne M., Mehta, Pankaj D., Hyman, Bradley T., Selkoe, Dennis J., Grodstein, Francine
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2737811/
https://ncbi.nlm.nih.gov/pubmed/19221417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-2009-0948
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires